Cross Timbers Royalty Trust
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRT research report →
Price Chart
About the company
Cross Timbers Royalty Trust functions as an express trust within the United States, holding substantial stakes in various energy-related assets. The trust maintains a 90% net profits interest across a selection of producing and nonproducing royalty and overriding royalty properties located in Texas, Oklahoma, and New Mexico. Additionally, it secures a 75% net profits working interest in seven specific properties, four of which are situated in Texas and three in Oklahoma.
- CEO
- Nancy G. Willis
- IPO
- 1992
- HQ
- Dallas, TX, US
Get TickerSpark's AI analysis on CRT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $75.00M
- P/E
- 24.46
- PEG
- -0.56
- P/S
- 17.75
- P/B
- 36.43
- EV/EBITDA
- 22.52
- Div Yield
- 6.69%
- Gross Margin
- 96.72%
- Op Margin
- 73.74%
- Net Margin
- 74.04%
- ROE
- 147.70%
- ROIC
- 88.14%
Latest fiscal year · YoY change
- Revenue
- $5.79M-11.8%
- Gross Profit
- $5.51M-16.0%
- Op Income
- $4.49M
- Net Income
- $4.49M-20.9%
- EPS
- $0.75-21.1%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $14.63
- 52W Low
- $7.34
- 50D MA
- $12.42
- 200D MA
- $10.55
- Beta
- -0.02
- RSI (14)
- 46
- Avg Volume
- 24.81K
No earnings-call transcripts are available for CRT yet.
- Free Float
- 100.0%
- Shares Outstanding
- 6.00M
- Float Shares
- 6.00M
of shares held by institutions
21 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CRT, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Virginia Ann FoxxHouse · NC05 | Sell | Jan 17, 24 | Filing → |
| Virginia Ann FoxxHouse · NC05 | Buy | Dec 8, 23 | Filing → |
| Virginia Ann FoxxHouse · NC05 | Buy | Nov 28, 23 | Filing → |
| Virginia Ann FoxxHouse · NC05 | Buy | Nov 29, 23 | Filing → |
| Virginia Ann FoxxHouse · NC05 | Buy | Oct 2, 23 | Filing → |
| Virginia Ann FoxxHouse · NC05 | Buy | Sep 19, 23 | Filing → |
| Virginia Ann FoxxHouse · NC05 | Buy | May 1, 23 | Filing → |
| Virginia Ann FoxxHouse · NC05 | Buy | May 17, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Softvest Advisors, LLC | 924.96K | ▲ 227.07K |
| Ashton Thomas Private Wealth, LLC | 239.92K | 0 |
| Beacon Pointe Advisors, LLC | 69.29K | ▲ 6.49K |
| Morgan Stanley | 20.98K | ▲ 14.79K |
| Welch Group, LLC | 16.65K | 0 |
| Waddell & Associates, LLC | 15.91K | ▲ 144 |
| Xtx Topco Ltd | 10.96K | ▲ 10.96K |
| Susquehanna International Group, Llp | 10.68K | ▲ 10.68K |
| O'Shaughnessy Asset Management, LLC | 10.66K | ▲ 10.66K |
| Ubs Group AG | 6.50K | ▼ 1.05K |
| Wells Fargo & Company/Mn | 1.98K | 0 |
| Harbour Investments, Inc. | 1.80K | 0 |
Held by 1 ETFs
Biggest fund positions in CRT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 13, 26 | OLIVER ERIC L | buy | 1,377 |
| Oct 12, 26 | OLIVER ERIC L | buy | 4,817 |
| Oct 8, 26 | OLIVER ERIC L | buy | 6,041 |
| Oct 7, 26 | OLIVER ERIC L | buy | 1,318 |
| Sep 11, 26 | OLIVER ERIC L | buy | 16,360 |
| Sep 9, 26 | OLIVER ERIC L | buy | 7,134 |
| Sep 8, 26 | OLIVER ERIC L | buy | 6,142 |
| Sep 4, 26 | OLIVER ERIC L | buy | 5,473 |
| Sep 3, 26 | OLIVER ERIC L | buy | 790 |
| Sep 2, 26 | OLIVER ERIC L | buy | 2,289 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CRT coverage
Recent articles, reports, and earnings notes.
No research on CRT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRT report →CT Real Estate Investment Trust (CRT.UN:CA) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 10
Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer
gurufocus.com · Oct 24
IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial
gurufocus.com · Oct 24
Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium
gurufocus.com · Oct 22
CROSS TIMBERS ROYALTY TRUST DECLARES OCTOBER CASH DISTRIBUTION
prnewswire.com · Oct 20
New Signatera™ Data Presented at ASTRO Conference, Highlights Utility for Radiation Oncologists
gurufocus.com · Oct 6
Analyzing Cross Timbers Royalty Trust (NYSE:CRT) and Navigator (NYSE:NVGS)
defenseworld.net · Oct 4
Cross Timbers Royalty Trust (CRT) To Go Ex-Dividend on September 30th
defenseworld.net · Sep 28
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.